Anti-MRP2 抗体 [M2III-5] (ab15603)

ab15603 は 7 報の論文で使用されています。

• Hardwick RN  et al. Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis. Drug Metab Dispos 40:450-60 (2012). WB ; Rat . PubMed: 22112382
• Saeki J  et al. LPS-induced dissociation of multidrug resistance-associated protein 2 (Mrp2) and radixin is associated with Mrp2 selective internalization in rats. Biochem Pharmacol 81:178-84 (2011). WB, IHC-Fr ; Rat . PubMed: 20868650
• Hardwick RN  et al. Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease. Drug Metab Dispos 39:2395-402 (2011). WB ; Human . PubMed: 21878559
• Sekine S  et al. Oxidative stress is a triggering factor for LPS-induced Mrp2 internalization in the cryopreserved rat and human liver slices. Biochem Biophys Res Commun 399:279-85 (2010). IHC-Fr ; Human, Rat . PubMed: 20655877
• Ogura J  et al. Alteration of Mrp2 and P-gp expression, including expression in remote organs, after intestinal ischemia-reperfusion. Life Sci 82:1242-8 (2008). WB ; Rat . PubMed: 18538350
• Yang XX  et al. A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor. J Pharmacol Exp Ther 319:82-104 (2006). WB ; Rat . PubMed: 16815871
• Scheffer GL  et al. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res 60:5269-77 (2000). PubMed: 11016657